Israeli patients aged 70 and older were much less likely to require mechanical ventilation for COVID-19 after most people in their age group had received the second dose of the Pfizer vaccine, according to a study released today by the Centers for Disease Control and Prevention.

Israel initiated a national vaccination campaign using the Pfizer vaccine in December, prioritizing people over 60, health care workers and people with underlying medical conditions. By February, the ratio of COVID-19 patients aged 70 and older requiring mechanical ventilation declined 67% compared with that of patients under 50, the least vaccinated age group.

The authors said the findings provide preliminary evidence of the effectiveness of vaccines in preventing severe cases of COVID-19 in Israel.

Related News Articles

Headline
The Food and Drug Administration July 15 announced a recall by Sandoz on certain lots of cefazolin, due to the lots being mislabeled as penicillin G potassium…
Headline
 The Food and Drug Administration July 10 approved Moderna’s Spikevax COVID-19 vaccine for children under 12 with at least one underlying condition that…
Headline
The Occupational Safety and Health Administration June 30 released a proposed rule to remove what remains of its emergency temporary standard for occupational…
Headline
Department of Health and Human Services Secretary Robert F. Kennedy Jr. May 27 announced in a post on X that the Centers for Disease Control and Prevention…
Headline
Leaders of the Food and Drug Administration May 20 announced new guidelines for administering the COVID-19 vaccine in a paper published by the New England…
Headline
A study published April 8 by the Public Library of Science’s Journal of Global Public Health found that driving while infected with COVID-19 raises the risk of…